UNDERWRITING AGREEMENTUnderwriting Agreement • September 14th, 2017 • TCF Financial Corp • National commercial banks • New York
Contract Type FiledSeptember 14th, 2017 Company Industry Jurisdictionto December 1, 2022 within 90 days of a “regulatory capital treatment event,” as described in the prospectus supplement, at a redemption price equal to $25,000 per share (equivalent to $25 per depositary share), plus any declared and unpaid dividends for prior dividend periods, without accumulation of any undeclared dividends. Neither the holders of Series C Preferred Stock nor holders of depositary shares will have the right to require the redemption or repurchase of the Series C Preferred Stock.
UNDERWRITING AGREEMENTUnderwriting Agreement • December 18th, 2012 • TCF Financial Corp • National commercial banks • New York
Contract Type FiledDecember 18th, 2012 Company Industry JurisdictionTCF Financial Corporation, a Delaware corporation (the “Company”), proposes to issue, or cause to be issued, and sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you are acting as managers (the “Managers”), the number of shares of 6.45% Series B Non-Cumulative Perpetual Preferred Stock, par value $0.01 per share, liquidation preference of $25 per share (the “Preferred Stock”) set forth in Schedule I hereto (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than the number of additional shares of Preferred Stock set forth in Schedule I hereto (the “Additional Shares”) if and to the extent that you, as Managers of the offering, shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of Preferred Stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Securities.”